NBC BostonBoston Doctors Seeing More Paxlovid Rebound in COVID PatientsJun 15, 2022Mary MarkosBy Mary Markosmore_vert
ReutersPfizer stops enrollment in Paxlovid trial in standard-risk populationJun 14, 2022Leroy LeoBy Leroy Leomore_vert
STATPfizer's Paxlovid study fails to answer key questions over benefit for broader populationsJun 14, 2022Matthew Herper & Jason MastBy Matthew Herper & Jason Mastmore_vert